Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1987; 57(02): 234
DOI: 10.1055/s-0038-1651102
DOI: 10.1055/s-0038-1651102
Letters to the Editor
Low Molecular Weight Heparin (CY 216) Does Not Cross the Placenta During the Third Trimester of Pregnancy
Further Information
Publication History
Received 11 November 1986
Accepted after revision 17 December 1986
Publication Date:
23 July 2018 (online)
-
References
- 1 Letsky EA, Swiet MD. Thromboembolism in pregnancy and its management. Br J Haematol 1984; 57: 543-552
- 2 Aiach M, Michael A, Balian JL, Lefevre M, Woler M, Fourtillon J. A new low molecular weight heparin derivative. In vitro and in vivo studies. Thromb Res 1983; 31: 611-621
- 3 Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound. A study of 606 consecutive cases. Am J Obstet Gynecol 1985; 153: 655-660
- 4 Andrew M, Ofosu F, Fernandez F, Jefferies A, Hirsh J, Mitchell L, Buchanan MR. A low molecular weight heparin alters the fetal coagulation system in the pregnant sheep. Thromb Haemostas 1986; 55: 342-346
- 5 Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy: Study by direct fetal blood sampling under ultrasound. Thromb Res 1984; 34: 557
- 6 Henny ChP, Ten Cate H, Ten Cate JW, Prummel MF, Peters M, Buller HR. Thrombosis prophylaxis in an AT III deficient pregnant women: application of a low molecular weight heparinoid. Thromb Haemostas 1986; 55: 301